Alpha Cognition is a clinical stage, biopharmaceutical company dedicated to developing novel treatments for under-served neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS). ALPHA-1062, a patented new chemical entity that has demonstrated safety and improved tolerability in human clinical trials. It is being developed as a new acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer’s type, with minimal gastrointestinal side-effects and novel routes of administration. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS. ALPHA-0602 is patented and has received Orphan Drug Designation from the FDA.
View Top Employees from Alpha Cognition, Inc.| Website | http://www.alphacognition.com/ |
| Employees | 7 (5 on RocketReach) |
| Address | 301-1228 Hamilton St, Vancouver, British Columbia V6B 6L2, CA |
| Phone | (604) 619-0990 |
| Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Retail |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Alpha Cognition, Inc. employee's phone or email?
Alpha Cognition, Inc. Questions
Lauren D'Angelo is the Chief Commercial Officer of Alpha Cognition, Inc..
5 people are employed at Alpha Cognition, Inc..
Alpha Cognition, Inc. is based in Vancouver, British Columbia.
The NAICS codes for Alpha Cognition, Inc. are [32, 325, 32541, 3254].
The SIC codes for Alpha Cognition, Inc. are [283, 28].
Top Alpha Cognition, Inc. Employees
-
View
Denis Kay
Co-Founder and Chief Scientific Officer at Alpha Cognition Inc. at Alpha Cognition, Inc.
Charlottetown, PE, CA54 -
43
-
22
-
1
Related Companies
